Engaging Antibiotech Activists

As described in the Editorial1 I have also moved from avoiding dialog with activists (or reading their literature) to realizing that there are thoughtful protestors who are truly concerned with wider issues of biotechnology.However, my first attempt to talk to a member of an activist organization, who was also a scientist, was not a happy one. All of us who were later to participate in a round-table discussion were having lunch. This person was most reasonable at lunchtime, and since he was a sc

Written byMertxe de Renobales Scheifler
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

As described in the Editorial1 I have also moved from avoiding dialog with activists (or reading their literature) to realizing that there are thoughtful protestors who are truly concerned with wider issues of biotechnology.

However, my first attempt to talk to a member of an activist organization, who was also a scientist, was not a happy one. All of us who were later to participate in a round-table discussion were having lunch. This person was most reasonable at lunchtime, and since he was a scientist working in a leading university, he did understand the science very well.

As soon as he sat down at the public round-table discussion, however, he put on his activist costume and none of us were able to recognize him any longer. This has happened to me several times: In private, I have found many reasonable and thoughtful activists who have immediately taken the confrontational position ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies